Table 3.
AUCs of SPH in the Prediction of pCR at Different Treatment Time Points
| Cohort | N | pCR Rate | T0 | T1 |
|---|---|---|---|---|
| Full | 935 | 33% | 0.61 (0.57, 0.65) | 0.58 (0.55, 0.62) |
| HR+/HER2− | 365 | 18% | 0.61 (0.53, 0.68) | 0.58 (0.49, 0.66) |
| HR+/HER2+ | 148 | 40% | 0.58 (0.48, 0.67) | 0.53 (0.43, 0.62) |
| HR−/HER2+ | 80 | 61% | 0.67 (0.54, 0.80) | 0.63 (0.51, 0.76) |
| HR−/HER2− | 342 | 41% | 0.64 (0.58, 0.70) | 0.62 (0.56, 0.68) |
Abbreviations: AUC, area under the curve; pCR, pathologic complete response; HR, hormone receptor; HER2, human epidermal growth factor receptor 2.